COHANCENSECohance Lifesciences LimitedMediumNeutral
Announced Mon, 30 Mar · 22:11 IST

Cohance Lifesciences Limited has informed the Exchange regarding Appointment of Mr Sisir K. Mishra as Company Secretary & Compliance Officer of the company w.e.f. April 09, 2026.

Management Changes View source PDF

COHANCE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.7%1-day move
₹302.85
prior close
₹308.95
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.2+0.0-0.1-0.5+1.7+0.9-1.1+2.2+5.7+18.2+18.5+54.2+41.7+48.9
Up moveDown movePending
AI summary

Cohance Lifesciences Limited has appointed Mr. Sisir K. Mishra as its Company Secretary, Compliance Officer and Key Managerial Personnel, effective April 9, 2026. The appointment was approved by the Board on March 30, 2026, based on the recommendation of the Nomination and Remuneration Committee. Mr. Mishra is a Fellow Member of the Institute of Company Secretaries of India, holds an LL.M. from Osmania University, and brings over two decades of experience in corporate secretarial, legal, governance, CSR and ESG functions across infrastructure, manufacturing, IT and power sectors. He has previously served as Company Secretary at NCC Limited, Paradeep Phosphates Limited, Deccan Cements Limited and KSK Group.

Likely market impact

This is a routine key managerial personnel appointment and is not expected to materially impact the stock price. It strengthens the company's governance and compliance team, which is a neutral-to-positive signal for corporate governance standards.